Bausch + Lomb Corp

NYSE: BLCO
$14.31
+$0.24 (+1.7%)
Closing price April 17, 2024
Bausch + Lomb Corporation, headquartered in Vaughan, Canada, is a global leader in eye health. Founded in 1853, it offers a wide range of products across three main segments: Vision Care, Ophthalmic Pharmaceuticals, and Surgical. The company provides everything from contact lenses and eye care products to pharmaceuticals for treating eye conditions like glaucoma and dry eyes, as well as surgical devices and technologies for eye conditions. As a key subsidiary of Bausch Health Companies Inc., Bausch + Lomb is dedicated to addressing the full spectrum of eye health needs.
Monday's top analyst upgrades and downgrades included AMC Entertainment, Arch Resources, Bausch + Lomb, Lazard, Lucid, MicroStrategy and Paychex.
Thursday's top analyst upgrades and downgrades included Carvana, FedEx, First Solar, Generac, Nike, PagSeguro Digital, Palantir Technologies, Redfin, Regions Financial, Starbucks, Target and Workday.